Monday, October 26, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatoryretatrutidegray marketeli lillycounterfeit

Bodega retatrutide vial contained phenylacetic acid and 13 bacterial colonies

A University of Iowa chemist told CBS the sample bought at a Brooklyn corner store did not resemble a peptide at all.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 24 11:55 ETSource: Futurism

The wire

  1. 01CBS sent a vial labeled retatrutide, purchased from a Brooklyn bodega, to University of Iowa bioorganic chemistry researcher Jason Galpin, who found phenylacetic acid rather than any peptide, plus at least 13 bacterial colonies.
  2. 02Retatrutide is not yet approved or released by Eli Lilly, so every consumer vial on the gray market is counterfeit or unverified; injected bacterial contamination can seed infection, a university official told CBS.
  3. 03Wired reported a similar Brooklyn purchase last month that lab technicians could not identify; neither test is a systematic survey of the gray-market supply.

From the source

Someone Ran a Chemical Analysis of Bodega Retatrutide and Dear Lord

Like gas station kratom, research-grade peptides have become widely available for consumers at convenience stores across the United States. Yet as one investigation into peptides sourced from a New York City bodega found, ease of access comes with a high price: your health.

Read at futurism.com
PeptiPrescribed peptides from $99/moSee all →